Presymptomatic genetic testing for neurodegenerative diseases can help patients make effective treatment decisions, but the medical profession needs to ensure that the increasing use of the tests is done responsibly.
The president of the Association of American Medical Colleges gives reasons why medical schools need to continue affirmative action admissions policies.
Physicians need to understand when it may be appropriate to let patients get involved in medical decision-making and when it may be necessary to provide their personal medical judgment.